Results per Page:
When on-target misses the mark: Lessons from HIV immunogens
From the McGuire Lab, Vaccine and Infectious Disease Division
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees
Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential
Anti-(idio)typical: a new immunogen to vaccinate against RSV
From the McGuire Lab, Vaccine & Infectious Disease Division
Laying the groundwork for a new cancer-preventive vaccine
Fred Hutch scientists garner large NCI award to uncover secrets of immune response to virus behind Kaposi sarcoma
Going straight to the source in defense against infant RSV
New anti-idiotype antibody a first step in possible strategy to build infant immunity during vulnerable window
Repping Epstein-Barr virus: RNA vaccine protects against cancer in mice
From the McGuire lab, Vaccine and Infectious Disease Division
A (literally) multi-pronged viral vaccine approach
From the McGuire Lab, Vaccine and Infectious Disease Division
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Researchers advance development of potential Epstein-Barr virus vaccines
Stakes raised as common virus linked to more diseases
Do viruses have heads, shoulders, knees, and toes?
From the Stamatatos, Pancera and McGuire labs, Vaccine and Infectious Disease Division
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
Natural protection from COVID-19 gets boost from a single dose of vaccine
Tests of patients' blood show vaccine stirs antibodies against variants and 2003 SARS virus
A year of research dominated by the coronavirus
Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer
Scientists map structure of potent antibody against coronavirus
Computer-generated images show why immune protein neutralizes SARS-CoV-2
Antibodies a hot topic in COVID-19 research
Hutch scientists tap their antibody expertise for new tests, treatments, vaccines
Antibody blocks Epstein-Barr virus in preclinical trial
Hutch-discovered protein blocks virus linked to cancers, mono, autoimmune diseases
Clues from coronavirus’ past
From the University of Washington and the McGuire lab, Vaccine and Infectious Disease Division
New research projects aim to advance COVID-19 testing, treatment
Projects by Drs. Keith Jerome, Andrew McGuire funded by $350,000 gift from M.J. Murdock Charitable Trust